Login / Signup

Dual targeting of Toll-like receptor 4 and angiotensin-converting enzyme 2: a proposed approach to SARS-CoV-2 treatment.

Laura Kate GadanecTawar QaradakhiKristen Renee McSweeneyBenazir Ashiana AliAnthony ZulliVasso Apostolopoulos
Published in: Future microbiology (2021)
Keyphrases
  • toll like receptor
  • angiotensin converting enzyme
  • sars cov
  • angiotensin ii
  • nuclear factor
  • inflammatory response
  • immune response
  • cancer therapy
  • respiratory syndrome coronavirus
  • replacement therapy